hitting the breaks

Once-popular bus service departs Houston and Texas after bankruptcy filing

You won't be seeing any Megabus vehicles traversing Texas highways any more. Photo via Getty Images

Texans lost a more sustainable way of traveling the Lone Star State this month.

Megabus, the cheap and efficient bus company that offered rides for as low as $1, has ended service across Texas, including all routes operating between Austin, Dallas, Grand Prairie, Houston, and San Antonio.

According to a notice on the company's website, they shut down the Texas routes on August 16 as part of a set of new nationwide route changes that also included offloading other routes to competing operators.

Known for its eye-catching double-decker royal blue buses, Megabus was first launched in the U.K. in 2003, then came to the U.S. in 2006. It generated considerable excitement when it entered the Texas market in 2012, by offering free Wi-Fi, restrooms, and fares for as low as $1.

The changes come after Coach USA, Megabus' owner, filed for Chapter 11 bankruptcy, winning court approval to sell its Megabus service in July. The company blamed its bankruptcy on a decline in ridership during the pandemic.

Shutdowns:

  • Routes operating between Atlanta, Charlotte, Durham, Richmond, and Washington, D.C. will be discontinued as of August 16th, 2024. Customers with tickets booked on these services have been notified and refunds have been processed.
  • Routes operating between Dallas, Austin, San Antonio, and Houston will be discontinued as of August 16th, 2024. Customers with tickets booked on these services have been notified and refunds have been processed.

New operators:

  • Routes operating between New York, Baltimore, Philadelphia, and Washington, D.C. will be operated by Peter Pan Bus Lines
  • Routes operating between New York, State College, Harrisburg, King of Prussia, and Pittsburgh will be operated by Fullington Trailways

All other routes in the United States and Canada will operate as normal.

Megabus still operates in more than 500 different cities and university campuses across the U.S., including several popular routes between New York, Philadelphia, and Washington, D.C.

———

This article originally ran on CultureMap.

Trending News

A View From HETI

Energy Transfer, a Dallas-based midstream energy company, just donated $100,000 to Houston Methodist. Photo via Getty Images

Where do energy transition and life-saving medicine meet? In Texas, of course.

Energy Transfer, a Dallas-based midstream energy company, just donated $100,000 to Houston Methodist. The grant is part of a $200,000 gift that has spanned the past two years. The goal? To eradicate the neurological disorder, ALS (amyotrophic lateral sclerosis). There is currently no cure for ALS. For roughly 90 percent of patients, there’s no known genetic cause, meaning the disease can strike anyone.

Houston Methodist currently has numerous clinical trials taking place with the goal to slow or halt the progression of the degenerative ailment.

“Every dollar donated to ALS research is a beacon of hope for those battling the disease,” said Chris Curia, executive vice president and chief human resources officer at Energy Transfer. “Those affected by ALS deserve a chance at a better life. We are hopeful this donation brings us one step closer to a world without this disease.”

Houston Methodist is home to the first multidisciplinary care clinic for ALS patients in the region and is actively engaged in both clinical and basic scientific research to support people battling ALS.

“We appreciate Energy Transfer’s generosity in our efforts to improve the quality of life and to provide hope for ALS patients and their families. Their continued commitment to Houston Methodist’s ongoing ALS research is truly transformational,” says Stanley H. Appel, M.D., a pioneering neurologist at Houston Methodist whose lab focuses on neurodegenerative diseases, including ALS.

Energy Transfer’s gift will help to support one particularly promising trial of a combination therapy that is currently moving into Phase 2. In its first phase, the therapy was found to safely slow disease progression in four ALS patients over a six-month period. Those patients had no significant progression of their disease during the trial. Prior to receiving the therapy, each of the patients had reported declining abilities to perform daily tasks.

Energy Transfer’s good deed could mean the world not only to patients at Houston Methodist, but to ending ALS altogether.

Trending News